Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 6/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | ANPEP | P15144 | 1/20 | 0.30 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19172293 | 0.84 | KDM4E (0.38) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL18392094 | 0.82 | KDM4E (0.39) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL21064487 | 0.80 | PDK2 (0.47) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL23746045 | 0.75 | CYP2D6 (0.50) | PDK2CYP2D6GABRA1GABRB2KDM4E | |
| SCHEMBL21303336 | 0.74 | PDK2 (0.49) | PDK2CYP2D6HTR7HTR2BGABRA1 | |
| SCHEMBL29488299 | 0.72 | MEN1 (0.60) | PDK2CYP2D6HTR7HTR2BGABRA1 | |
| SCHEMBL18079825 | 0.71 | ADORA2A (0.42) | PDK2CYP2D6KDM4EMEN1LMNA | |
| SCHEMBL20889206 | 0.70 | KDM4E (0.42) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL18466391 | 0.70 | MEN1 (0.44) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL16544651 | 0.70 | PDK2 (0.41) | PDK2CYP2D6KDM4ELMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10312459-B2 | Compound and organic electronic device using the same | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2019-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10312459-B2 | Compound and organic electronic device using the same | OR51E2, OR10J3, ESR1 | PDK2 1279/4885CYP2D6 57/4885HTR7 3956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.